BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05925530-completion@plaintrial.com
DTSTAMP:20261029T083033Z
DTSTART;VALUE=DATE:20270827
SUMMARY:Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemo
 therapy (CT)\, Followed by Either Surgery and Adjuvant D or CRT and Consol
 idation D\, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (M
 DT-BRIDGE) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05925530
URL:https://plaintrial.com/trial/NCT05925530
END:VEVENT
END:VCALENDAR